Links between innate immunity and normal tissue radiobiology

Radiation Research

Volumn 173, Issue 4, 2010, Pages 406-417

  Schaue, Drthe ^a   McBride, William H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DEATH RECEPTOR 3; DEATH RECEPTOR 4; DEATH RECEPTOR 5; FAS ANTIGEN; FREE RADICAL; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 7; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 18; MYELOID DIFFERENTIATION FACTOR 88; PLATELET DERIVED GROWTH FACTOR; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TRANSCRIPTION FACTOR AP 1; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

CELL DAMAGE; CELL PROTECTION; CELL TYPE; CYTOKINE PRODUCTION; FEEDBACK SYSTEM; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATION; INFLAMMATORY CELL; INNATE IMMUNITY; MACROPHAGE; MULTIGENE FAMILY; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; RADIATION RESPONSE; RADIOBIOLOGY; REVIEW; SIGNAL TRANSDUCTION; TISSUE INJURY; TISSUE REACTION; TISSUE REGENERATION; WOUND HEALING;

ANIMALS; HUMANS; IMMUNITY, INNATE; IMMUNOLOGIC FACTORS; INFLAMMATION; MODELS, IMMUNOLOGICAL; RADIATION TOLERANCE; RECEPTORS, PATTERN RECOGNITION;

EID: 77950254153     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR1931.1     Document Type: Review

References (113)

1. C. A. Janeway Jr. The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol. Today 13, 11-16 (1992)
2. R. Medzhitov, P. Preston-Hurlburt and C. A. Janeway, Jr., A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388, 394-397 (1997).
3. E. Meylan, J. Tschopp and M. Karin, Intracellular pattern recognition receptors in the host response. Nature 442, 39-44 (2006).
4. M. J. Robinson, D. Sancho, E. C. Slack, S. LeibundGut-Landmann and C. Reis e Sousa, Myeloid C-type lectins in innate immunity. Nat. Immunol. 7, 1258-1265 (2006).
5. M. T. Lotze, H. J. Zeh, A. Rubartelli, L. J. Sparvero, A. A. Amoscato, N. R. Washburn, M. E. Devera, X. Liang, M. Tor and T. Billiar, The grateful dead: damage-associated molecular pattern molecules and reduction/oxidation regulate immunity. Immunol. Rev. 220, 60-81 (2007).
6. S. Y. Seong and P. Matzinger, Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. Nat. Rev. Immunol. 4, 469-478 (2004).
7. J. Kluwe, A. Mencin and R. F. Schwabe, Toll-like receptors, wound healing, and carcinogenesis. J. Mol. Med. 87, 125-138 (2009).
8. L. A. O'Neill, The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress. Immunol. Rev. 226, 10-18 (2008).
9. L. Apetoh, F. Ghiringhelli, A. Tesniere, M. Obeid, C. Ortiz, A. Criollo, G. Mignot, M. C. Maiuri, E. Ullrich and L. Zitvogel, Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat. Med. 13, 1050-1059 (2007).
10. K. Miyake, Nucleic acid-sensing Toll-like receptors: beyond ligand search. Adv. Drug Deliv. Rev. 60, 782-785 (2008).
11. S. Akira, TLR signaling. Curr. Top Microbiol Immunol. 311, 1-16 (2006).
12. P. Matzinger, An innate sense of danger. Ann. NY Acad. Sci. 961, 341-342 (2002).
13. A. Tesniere, L. Apetoh, F. Ghiringhelli, N. Joza, T. Panaretakis, O. Kepp, F. Schlemmer, L. Zitvogel and G. Kroemer, Immunogenic cancer cell death: a key-lock paradigm. Curr. Opin. Immunol. 20, 504-511 (2008).
14. J. Banchereau and R. M. Steinman, Dendritic cells and the control of immunity. Nature 392, 245-252. (1998).
15. P. Matzinger, Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12, 991-1045 (1994).
16. R. Neta, S. Douches and J. J. Oppenheim, Interleukin 1 is a radioprotector. J. Immunol. 136, 2483-2485 (1986).
17. Y. X. Shan, S. Z. Jin, X. D. Liu, Y. Liu and S. Z. Liu, Ionizing radiation stimulates secretion of pro-inflammatory cytokines: dose-response relationship, mechanisms and implications. Radiat. Environ. Biophys. 46, 21-29 (2007).
18. K. Miyake, Y. Yamashita, M. Ogata, T. Sudo and M. Kimoto, RP105, a novel B cell surface molecule implicated in B cell activation, is a member of the leucine-rich repeat protein family. J. Immunol. 154, 3333-3340 (1995).
19. S. Divanovic, A. Trompette, L. K. Petiniot, J. L. Allen, L. M. Flick, Y. Belkaid, R. Madan, J. J. Haky and C. L. Karp, Regulation of TLR4 signaling and the host interface with pathogens and danger: the role of RP105. J. Leukoc. Biol. 82, 265-271 (2007).
20. A. Debucquoy, L. Libbrecht, V. Roobrouck, L. Goethals, W. McBride and K. Haustermans, Morphological features and molecular markers in rectal cancer from 95 patients included in the European Organisation for Research and Treatment of Cancer 22921 trial: prognostic value and effects of preoperative radio (chemo) therapy. Eur. J. Cancer 44, 791-797 (2008).
21. L. Zitvogel, L. Apetoh, F. Ghiringhelli, F. Andre, A. Tesniere and G. Kroemer, The anticancer immune response: indispensable for therapeutic success? J. Clin. Invest. 118, 1991-2001 (2008).
22. E. Cario, I. M. Rosenberg, S. L. Brandwein, P. L. Beck, H. C. Reinecker and D. K. Podolsky, Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing Toll-like receptors. J. Immunol. 164, 966-972 (2000).
23. S. C. Gribar, W. M. Richardson, C. P. Sodhi and D. J. Hackam, No longer an innocent bystander: epithelial toll-like receptor signaling in the development of mucosal inflammation. Mol. Med. 14, 645-659 (2008).
24. T. T. Macdonald and G. Monteleone, Immunity, inflammation, and allergy in the gut. Science 307, 1920-1925 (2005).
25. S. C. Gribar, R. J. Anand, C. P. Sodhi and D. J. Hackam, The role of epithelial Toll-like receptor signaling in the pathogenesis of intestinal inflammation. J. Leukoc. Biol. 83, 493-498 (2008).
26. M. D. Neal, C. Leaphart, R. Levy, J. Prince, T. R. Billiar, S. Watkins, J. Li, S. Cetin, H. Ford and D. J. Hackam, Enterocyte TLR4 mediates phagocytosis and translocation of bacteria across the intestinal barrier. J. Immunol. 176, 3070-3079 (2006).
27. S. Rakoff-Nahoum, L. Hao and R. Medzhitov, Role of tolllike receptors in spontaneous commensal-dependent colitis. Immunity 25, 319-329 (2006).
28. J. H. Lee, B. Lee, H. S. Lee, E. A. Bae, H. Lee, Y. T. Ahn, K. S. Lim, C. S. Huh and D. H. Kim, Lactobacillus suntoryeus inhibits pro-inflammatory cytokine expression and TLR-4-linked NF-kappaB activation in experimental colitis. Int. J. Colorectal Dis. 24, 231-237 (2009).
29. S. Rakoff-Nahoum, J. Paglino, F. Eslami-Varzaneh, S. Edberg and R. Medzhitov, Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118, 229-241 (2004).
30. H. Xiao, M. F. Gulen, J. Qin, J. Yao, K. Bulek, D. Kish, C. Z. Altuntas, D. Wald, C. Ma and X. Li, The Toll-interleukin-1 receptor member SIGIRR regulates colonic epithelial homeostasis, inflammation, and tumorigenesis. Immunity 26, 461-475 (2007).
31. H. Clevers, At the crossroads of inflammation and cancer. Cell 118, 671-674 (2004).
32. M. Vijay-Kumar, H. Wu, R. Jones, G. Grant, B. Babbin, T. P. King, D. Kelly, A. T. Gewirtz and A. S. Neish, Flagellin suppresses epithelial apoptosis and limits disease during enteric infection. Am. J. Pathol. 169, 1686-1700 (2006).
33. L. G. Burdelya, V. I. Krivokrysenko, T. C. Tallant, E. Strom, A. S. Gleiberman, D. Gupta, O. V. Kurnasov, F. L. Fort, A. L. Osterman and A. V. Gudkov, An agonist of toll-like receptor 5 has radioprotective activity in mouse and primate models. Science 320, 226-230 (2008).
34. M. Vijay-Kumar, J. D. Aitken, C. J. Sanders, A. Frias, V. M. Sloane, J. Xu, A. S. Neish, M. Rojas and A. T. Gewirtz, Flagellin treatment protects against chemicals, bacteria, viruses, and radiation. J. Immunol. 180, 8280-8285 (2008).
35. L. Janot, J. C. Sirard, T. Secher, N. Noulin, L. Fick, S. Akira, S. Uematsu, A. Didierlaurent, T. Hussell and F. Erard, Radioresistant cells expressing TLR5 control the respiratory epithelium's innate immune responses to flagellin. Eur. J. Immunol. 39, 1587-1596 (2009).
36. M. M. McLaughlin, M. P. Dacquisto, D. P. Jacobus and R. E. Horowitz, Effects of the germfree state on responses of mice to whole-body irradiation. Radiat. Res. 23, 333-349 (1964).
37. H. R. Jervis, M. M. McLaughlin and M. C. Johnson, Effect of neutron-gamma radiation on the morphology of the mucosa of the small intestine of germfree and conventional mice. Radiat. Res. 45, 613-628 (1971).
38. S. L. Pull, J. M. Doherty, J. C. Mills, J. I. Gordon and T. S. Stappenbeck, Activated macrophages are an adaptive element of the colonic epithelial progenitor niche necessary for regenerative responses to injury. Proc. Natl. Acad. Sci. USA 102, 99-104 (2005).
39. M. A. Ciorba and W. F. Stenson, Probiotic therapy in radiation-induced intestinal injury and repair. Ann. NY Acad. Sci. 1165, 190-194 (2009).
40. R. Kuhn, J. Lohler, D. Rennick, K. Rajewsky and W. Muller, Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75, 263-274 (1993).
41. J. O. Lindsay and H. J. Hodgson, Review article: the immunoregulatory cytokine interleukin-10\a therapy for Crohn's disease? Aliment Pharmacol. Ther. 15, 1709-1716 (2001).
42. V. Camerini, B. C. Sydora, R. Aranda, C. Nguyen, C. MacLean, W. H. McBride and M. Kronenberg, Generation of intestinal mucosal lymphocytes in SCID mice reconstituted with mature, thymus-derived T cells. J. Immunol. 160, 2608-2618 (1998).
43. R. K. Sellon, S. Tonkonogy, M. Schultz, L. A. Dieleman, W. Grenther, E. Balish, D. M. Rennick and R. B. Sartor, Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect. Immun. 66, 5224-5231 (1998).
44. G. R. Hill, Inflammation and bone marrow transplantation. Biol. Blood Marrow Transplant. 15, 139-141 (2008).
45. A. Mantovani, A. Sica and M. Locati, Macrophage polarization comes of age. Immunity 23, 344-346 (2005).
46. W. H. McBride, C. S. Chiang, J. L. Olson, C. C. Wang, J. H. Hong, F. Pajonk, G. J. Dougherty, K. S. Iwamoto, M. Pervan and Y. P. Liao, A sense of danger from radiation. Radiat. Res. 162, 1-19 (2004).
47. G. Hildebrandt, M. P. Seed, C. N. Freemantle, C. A. Alam, P. R. Colville-Nash and K. R. Trott, Effects of low dose ionizing radiation on murine chronic granulomatous tissue. Strahlenther. Onkol. 174, 580-588 (1998).
48. D. Schaue, J. Jahns, G. Hildebrandt and K. R. Trott, Radiation treatment of acute inflammation in mice. Int. J. Radiat. Biol. 81, 657-667 (2005).
49. K. R. Trott and F. Kamprad, Radiobiological mechanisms of anti-inflammatory radiotherapy. Radiother. Oncol. 51, 197-203 (1999).
50. W. H. McBride, F. Pajonk, C. S. Chiang and J. R. Sun, NF-kappa B, cytokines, proteasomes, and low-dose radiation exposure. Mil Med. 167, 66-67 (2002).
51. J-H. Hong, C-S. Chiang, J-R. Sun, H. R. Withers and W. H. McBride, Induction of c-fos and junB mRNA following in vivo brain irradiation. Mol. Brain Res. 48, 223-228 (1997).
52. M. Akashi, M. Hachiya, H. P. Koeffler and G. Suzuki, Irradiation increases levels of GM-CSF through RNA stabilization which requires an AU-rich region in cancer cells. Biochem. Biophys. Res. Commun. 189, 986-993 (1992).
53. G. Laroia, B. Sarkar and R. J. Schneider, Ubiquitin-dependent mechanism regulates rapid turnover of AU-rich cytokine mRNAs. Proc. Natl. Acad. Sci. USA 99, 1842-1846 (2002).
54. K. S. Iwamoto and C. L. Barber, Radiation-induced post-transcriptional control of M6P/IGF2r expression in breast cancer cell lines. Mol. Carcinog. 46, 497-502 (2007).
55. P. J. Blackshear, Tristetraprolin and other CCCH tandem zinc-finger proteins in the regulation of mRNA turnover. Biochem. Soc. Trans. 30, 945-952 (2002).
56. M. S. Sheikh, T. F. Burns, Y. Huang, G. S. Wu, S. Amundson, K. S. Brooks, A. J. Fornace, Jr. and W. S. el-Deiry, p53-dependent and-independent regulation of the death receptor KILLER/DR5 gene expression in response to genotoxic stress and tumor necrosis factor alpha. Cancer Res. 58, 1593-1598 (1998).
57. H. M. Shen and S. Pervaiz, TNF receptor superfamily-induced cell death: redox-dependent execution. FASEB J. 20, 1589-1598 (2006).
58. D. E. Hallahan, D. R. Spriggs, M. A. Beckett, D. W. Kufe and R. R. Weichselbaum, Increased tumor necrosis factor a mRNA after cellular exposure to ionizing radiation. Proc. Natl. Acad. Sci. USA 86, 10104-10107 (1989).
59. C. S. Chiang and W. H. McBride, Radiation enhances tumor necrosis factor alpha production by murine brain cells. Brain Res. 566, 265-269 (1991).
60. C. S. Chiang, W. H. McBride and H. R. Withers, Radiation-induced astrocytic and microglial responses in mouse brain. Radiother. Oncol. 29, 60-68 (1993).
61. H. Akca, S. Yenisoy, A. Yanikoglu and O. N. Ozes, Tumor necrosis factor-alpha-induced accumulation of tumor suppressor protein p53 and cyclin-dependent protein kinase inhibitory protein p21 is inhibited by insulin in ME-180S cells. Clin. Chem. Lab. Med. 40, 764-768 (2002).
62. M. Karin and A. Lin, NF-kappaB at the crossroads of life and death. Nat. Immunol. 3, 221-227 (2002).
63. M. A. O'Donnell, D. Legarda-Addison, P. Skountzos, W. C. Yeh and A. T. Ting, Ubiquitination of RIP1 regulates an NF-kappaB-independent cell-death switch in TNF signaling. Curr. Biol. 17, 418-424 (2007).
64. J. L. Daigle, J. H. Hong, C. S. Chiang and W. H. McBride, The role of tumor necrosis factor signaling pathways in the response of murine brain to irradiation. Cancer Res. 61, 8859-8865. (2001).
65. K. Inagaki-Ohara, S. Yada, N. Takamura, M. Reaves, X. Yu, E. Liu, I. Rooney, S. Nicholas, A. Castro and T. Lin, p53-dependent radiation-induced crypt intestinal epithelial cells apoptosis is mediated in part through TNF-TNFR1 system. Oncogene 20, 812-818 (2001).
66. Y. Wang, A. Meng, H. Lang, S. A. Brown, J. L. Konopa, M. S. Kindy, R. A. Schmiedt, J. S. Thompson and D. Zhou, Activation of nuclear factor kappaB in vivo selectively protects the murine small intestine against ionizing radiation-induced damage. Cancer Res. 64, 6240-6246 (2004).
67. N. Finnberg, J. J. Gruber, P. Fei, D. Rudolph, A. Bric, S. H. Kim, T. F. Burns, H. Ajuha, R. Page and W. S. El-Deiry, DR5 knockout mice are compromised in radiation-induced apoptosis. Mol. Cell. Biol. 25, 2000-2013 (2005).
68. T. Nakazawa, C. Nakazawa, A. Matsubara, K. Noda, T. Hisatomi, H. She, N. Michaud, A. Hafezi-Moghadam, J. W. Miller and L. I. Benowitz, Tumor necrosis factor-alpha mediates oligodendrocyte death and delayed retinal ganglion cell loss in a mouse model of glaucoma. J. Neurosci. 26, 12633-12641 (2006).
69. X. W. Huang, J. Yang, A. F. Dragovic, H. Zhang, T. S. Lawrence and M. Zhang, Antisense oligonucleotide inhibition of tumor necrosis factor receptor 1 protects the liver from radiation-induced apoptosis. Clin. Cancer Res. 12, 2849-2855 (2006).
70. M. Zhang, J. Qian, X. Xing, F. M. Kong, L. Zhao, M. Chen and T. S. Lawrence, Inhibition of the tumor necrosis factor-alpha pathway is radioprotective for the lung. Clin. Cancer Res. 14, 1868-1876 (2008).
71. R. Ansari, M. W. Gaber, B. Wang, C. B. Pattillo, C. Miyamoto and M. F. Kiani, Anti-TNFA (TNF-alpha) treatment abrogates radiation-induced changes in vascular density and tissue oxygenation. Radiat. Res. 167, 80-86 (2007).
72. T. F. Burns, E. J. Bernhard and W. S. El-Deiry, Tissue specific expression of p53 target genes suggests a key role for KILLER/ DR5 in p53-dependent apoptosis in vivo. Oncogene 20, 4601-4612 (2001).
73. K. J. Lindsay, P. J. Coates, S. A. Lorimore and E. G. Wright, The genetic basis of tissue responses to ionizing radiation. Br. J. Radiol. 80 (Spec. No. 1), S2-S6 (2007).
74. C. Bubici, S. Papa, K. Dean and G. Franzoso, Mutual crosstalk between reactive oxygen species and nuclear factor-kappa B: molecular basis and biological significance. Oncogene 25, 6731-6748 (2006).
75. B. M. Babior, The respiratory burst of phagocytes. J. Clin. Invest. 73, 599-601 (1984).
76. O. Inanami, J. L. Johnson, J. K. McAdara, J. E. Benna, L. R. Faust, P. E. Newburger and B. M. Babior, Activation of the leukocyte NADPH oxidase by phorbol ester requires the phosphorylation of p47PHOX on serine 303 or 304. J. Biol. Chem. 273, 9539-9543 (1998).
77. V. Brinkmann and A. Zychlinsky, Beneficial suicide: why neutrophils die to make NETs. Nat. Rev. Microbiol. 5, 577-582 (2007).
78. D. A. Wink and J. B. Mitchell, Chemical biology of nitric oxide: Insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide. Free Radic. Biol. Med. 25, 434-456 (1998).
79. A. J. Hobbs, J. M. Fukuto and L. J. Ignarro, Formation of free nitric oxide from L-arginine by nitric oxide synthase: direct enhancement of generation by superoxide dismutase. Proc. Natl. Acad. Sci. USA 91, 10992-10996 (1994).
80. J. B. Mitchell, W. DeGraff, S. Kim, J. A. Cook, J. Gamson, D. Christodoulou, M. Feelisch and D. A. Wink, Redox generation of nitric oxide to radiosensitize hypoxic cells. Int. J. Radiat. Oncol. Biol. Phys. 42, 795-798 (1998).
81. S. Singh, R. L. Cowen, E. C. Chinje and I. J. Stratford, The impact of intracellular generation of nitric oxide on the radiation response of human tumor cells. Radiat. Res. 171, 572-580 (2009).
82. 2-dependent activation of nuclear factor kappa B. Role in sensitization of human tumor cells to tumor necrosis factor-alpha-induced cytotoxicity. J. Biol. Chem. 276, 8918-8923 (2001).
83. Y. M. Kim, T. H. Kim, H. T. Chung, R. V. Talanian, X. M. Yin and T. R. Billiar, Nitric oxide prevents tumor necrosis factor alpha-induced rat hepatocyte apoptosis by the interruption of mitochondrial apoptotic signaling through S-nitrosylation of caspase-8. Hepatology 32, 770-778 (2000).
84. G. R. Jones, Free radicals in immunological killing: the case of tumor necrotising factor (TNF). Med. Hypotheses 21, 267-271 (1986).
85. N. Watanabe, Y. Niitsu, H. Neda, H. Sone, N. Yamauchi, M. Maeda and I. Urushizaki, Cytocidal mechanism of TNF: effects of lysosomal enzyme and hydroxyl radical inhibitors on cyto-toxicity. Immunopharmacol. Immunotoxicol. 10, 109-116 (1988).
86. H. Z. Ozsoy, N. Sivasubramanian, E. D. Wieder, S. Pedersen and D. L. Mann, Oxidative stress promotes ligand-independent and enhanced ligand-dependent tumor necrosis factor receptor signaling. J. Biol. Chem. 283, 23419-23428 (2008).
87. Y. S. Bae, S. W. Kang, M. S. Seo, I. C. Baines, E. Tekle, P. B. Chock and S. G. Rhee, Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. Role in EGF receptor-mediated tyrosine phosphorylation. J. Biol. Chem. 272, 217-221 (1997).
88. C. K. Joo, H. S. Kim, J. Y. Park, Y. Seomun, M. J. Son and J. T. Kim, Ligand release-independent transactivation of epidermal growth factor receptor by transforming growth factor-beta involves multiple signaling pathways. Oncogene 27, 614-628 (2008).
89. E. Sarsour, M. G. Kumar, L. Chaudhuri, A. L. Kalen and P. Goswami, Redox control of the cell cycle in health and disease. Antioxid. Redox Signal. 11, 2985-3011 (2009).
90. R. K. Schmidt-Ullrich, R. B. Mikkelsen, P. Dent, D. G. Todd, K. Valerie, B. D. Kavanagh, J. N. Contessa, W. K. Rorrer and P. B. Chen, Radiation-induced proliferation of the human A431 squamous carcinoma cells is dependent on EGFR tyrosine phosphorylation. Oncogene 15, 1191-1197 (1997).
91. M. H. Barcellos-Hoff and T. A. Dix, Redox-mediated activation of latent transforming growth factor-beta 1. Mol. Endocrinol. 10, 1077-1083 (1996).
92. M. Pervan, K. S. Iwamoto and W. H. McBride, Proteasome structures affected by ionizing radiation. Mol. Cancer Res. 3, 381-390 (2005).
93. C. Ernst and B. R. Christie, Temporally specific proliferation events are induced in the hippocampus following acute focal injury. J. Neurosci. Res. 83, 349-361 (2006).
94. S. A. Lorimore, P. J. Coates and E. G. Wright, Radiation-induced genomic instability and bystander effects: inter-related nontargeted effects of exposure to ionizing radiation. Oncogene 22, 7058-7069 (2003).
95. W. H. McBride and G. J. Dougherty, Radiotherapy for genes that cause cancer. Nat. Med. 1, 1215-1217 (1995).
96. J. A. Bonner, K. P. Raisch, H. Q. Trummell, F. Robert, R. F. Meredith, S. A. Spencer, D. J. Buchsbaum, M. N. Saleh, M. A. Stackhouse and H. W. Waksal, Enhanced apoptosis with combination C225/radiation treatment serves as the impetus for clinical investigation in head and neck cancers. J. Clin. Oncol. 18, 47S-53S (2000).
97. M. G. Vander Heiden, L. C. Cantley and C. B. Thompson, Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324, 1029-1033 (2009).
98. I. Samudio, M. Fiegl and M. Andreeff, Mitochondrial uncoupling and the Warburg effect: molecular basis for the reprogramming of cancer cell metabolism. Cancer Res. 69, 2163-2166 (2009).
99. K. A. Brand and U. Hermfisse, Aerobic glycolysis by proliferating cells: a protective strategy against reactive oxygen species. FASEB J. 11, 388-395 (1997).
100. C. S. Chiang, J. H. Hong, A. Stalder, J. R. Sun, H. R. Withers and W. H. McBride, Delayed molecular responses to brain irradiation. Int. J. Radiat. Biol. 72, 45-53 (1997).
101. J. Inumaru, O. Nagano, E. Takahashi, T. Ishimoto, S. Nakamura, Y. Suzuki, S. I. Niwa, K. Umezawa, H. Tanihara and H. Saya, Molecular mechanisms regulating dissociation of cell-cell junction of epithelial cells by oxidative stress. Genes Cells 14, 703-716 (2009).
102. H. Kasai, J. T. Allen, R. M. Mason, T. Kamimura and Z. Zhang, TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT). Respir. Res. 6, 56 (2005).
103. A. Banning and R. Brigelius-Flohe, NF-kappaB, Nrf2, and HO-1 interplay in redox-regulated VCAM-1 expression. Antioxid. Redox Signal. 7, 889-899 (2005).
104. J. M. Lee, M. J. Calkins, K. Chan, Y. W. Kan and J. A. Johnson, Identification of the NF-E2-related factor-2-dependent genes conferring protection against oxidative stress in primary cortical astrocytes using oligonucleotide microarray analysis. J. Biol. Chem. 278, 12029-12038 (2003).
105. S. Ghosh and M. Karin, Missing pieces in the NF-kappaB puzzle. Cell 109 (Suppl.), S81-S96 (2002).
106. W. Jin, H. Wang, W. Yan, L. Xu, X. Wang, X. Zhao, X. Yang, G. Chen and Y. Ji, Disruption of Nrf2 enhances upregulation of nuclear factor-kappaB activity, pro-inflammatory cytokines, and intercellular adhesion molecule-1 in the brain after traumatic brain injury. Mediators Inflamm. 2008, 725174 (2008).
107. W. Li, T. O. Khor, C. Xu, G. Shen, W. S. Jeong, S. Yu and A. N. Kong, Activation of Nrf2-antioxidant signaling attenuates NFkappaB-inflammatory response and elicits apoptosis. Biochem. Pharmacol. 76, 1485-1489 (2008).
108. S. D. Ricardo, H. van Goor and A. A. Eddy, Macrophage diversity in renal injury and repair. J. Clin. Invest. 118, 3522-3530 (2008).
109. K. Deonarine, M. C. Panelli, M. E. Stashower, P. Jin, K. Smith, H. B. Slade, C. Norwood, E. Wang, F. M. Marincola and D. F. Stroncek, Gene expression profiling of cutaneous wound healing. J. Trans. Med. 5, 11 (2007).
110. C. S. Chiang, W. C. Liu, S. M. Jung, F. H. Chen, C. R. Wu, W. H. McBride, C. C. Lee and J. H. Hong, Compartmental responses after thoracic irradiation of mice: strain differences. Int. J. Radiat. Oncol. Biol. Phys. 62, 862-871 (2005).
111. C. S. Tsai, F. H. Chen, C. C. Wang, H. L. Huang, S. M. Jung, C. J. Wu, C. C. Lee, W. H. McBride, C. S. Chiang and J. H. Hong, Macrophages from irradiated tumors express higher levels of iNOS, arginase-I and COX-2, and promote tumor growth. Int. J. Radiat. Oncol. Biol. Phys. 68, 499-507 (2007).
112. C. Herskind and H. P. Rodemann, Spontaneous and radiation-induced differentiation of fibroblasts. Exp. Gerontol. 35, 747-755 (2000).
113. S. Demaria and S. C. Formenti, Sensors of ionizing radiation effects on the immunological microenvironment of cancer. Int. J. Radiat. Biol. 83, 819-825 (2007).